MA2.1-F(ab)2 does not reach equilibrium and a significant proportion of molecules bound with one and two sites are found. For the lower-affinity antibody (PA2.1), estimates of the binding constants for one-and two-site interactions could be made. By simple Scatchard analysis the avidity of F(ab)2 or IgG is 1.3 x 109M-1, giving an enhancement factor of 68 between bivalent and univalent binding. This is a measure of the equilibrium constant for the interchange between bivalent and univalent binding. Analysis of the results with more realistic models indicates that the actual value is larger (103-104 M-1) than 68M-1. The avidities of F(ab)2 and IgG for HLA-A2 are identical, showing the Fc does not interfere with bivalent binding to cells.
The human histocompatability or HLA antigens are a polymorphic family of membrane glycoproteins that control the recognition of foreign antigens by thymus-derived lymphocytes (Matzinger & Zamoyska, 1982) . The classical transplantation antigens are considered here and they consist of a polymorphic membrane-bound glycoprotein of Mr 43000 associated with 112-microAbbreviations used: IgG1, immunoglobulin G,; PA2.1 and MA2.1, monoclonal antibodies initially characterized by Parham & Bodmer (1978) and McMichael et al. (1980) respectively; HLA antigens, human histocompatability antigens; F(ab)2, bivalent antigen-binding fragment produced by papain digestion of IgG, [this is to distinguish it from F(ab')2 which is commonly used for the bivalent fragment of IgG produced by pepsin digestion]; Fab, univalent fragment produced by mild reduction and alkylation of F(ab)2; Fc, non-antigenbinding fragment produced by papain digestion of IgG; phosphate-buffered saline, Dulbecco's phosphate-buffered saline, pH 7.2 (Gibco, Grand Island, NY, U.S.A.).
Vol. 216 globulin of Mr 12000 [for review, see Dorf (1981) and Parham & Strominger (1982) (Mason & Williams, 1980) . In the present study the binding properties of the monoclonal antibodies PA2. 1 and MA2.1 that define two highly specific alloantigenic determinants of the HLA-A2t molecule are described. In addition to A2, PA2.1 recognizes A28*, and MA2.1 recognizes B 17. Despite these clear differences in serological specificity, MA2.1 and PA2.1 strongly compete for binding to soluble (Holmes & Parham, 1983) and cell-surface A2 (Ways & Parham, 1983) . One aim of this study was to compare the binding of PA2.1 and MA2.1 to A2, A28*, B 17 and to three A2 variants. A second aim was to further characterize the binding of monoclonal antibodies to cell-surface antigens in a system where high genetic polymorphism can be used to experimental advantage. (Biddison et al., 1980a) ; A2M1 (Al, BW44,17) (Andreotti et al., 1980 ) was from Dr. P. Cresswell; and LCL 721.53 (A2) from Dr. R. DeMars (Kavathas et al., 1980) . The HL-60 myeloid cell line that expresses HLA-B17 was from Dr. F. Brodsky (Collins et al., 1977; Gallagher et al., 1979) . FMB (A l, w32; Bw l7, Bw44) is from this laboratory. B-cell lines were maintained in RPMI 1640 medium supplemented with 10% (v/v) foetal-calf serum, penicillin (100units/ml), streptomycin (100 units/ml), and L-glutamine (2 mM).
Materials and methods
Monoclonal antibodies and theirfragments PA2.1 (IgG,) and MA2.1 (IgGj) were purified from the ascites fluids of BALB/c mice carrying the monoclonal-antibody-producing cell line as a tumour F(ab)2 and Fab fragments were prepared after digestion of IgG with papain as described previously Ways & Parham, 1983) .
Radioactive labelling ofantibodies
Radioiodination of IgG and F(ab)2 was by the method of Hunter & Greenwood (1962) with modifications to permit quantification as described by Mason & Williams (1980) . '251-Fab were made by mild reduction and alkylation of 125I-F(ab)2 . '25I-F(ab)2 preparations were divided in two; one half was reduced with 10mM-cysteine at 37°C and alkylated with 50 mM-iodoacetamide in darkened tubes at 370C, the other half was mock-treated with the addition of buffer alone at 37°C. Preparations of 251I-Fab and 251I-F(ab)2 thus made were used in comparative studies.
Radioiodinated preparations were checked for activity and serological specificity by direct cellbinding assay on a panel of human B-cell lines of appropriate HLA type. The specific bindable radioactivity in the preparations ranged from 55 to 95%. In all cell-binding experiments the radioactivity bound to DAUDI cells that express no HLA-A,B,C was used as background and subtracted to give the specific binding .
Cell-binding assays
Equilibrium binding assays were based on the methods of Trucco et al. (1980) as modified by . Dilutions of '25I-antibody were incubated with cells in phosphate-buffered saline/ 0.1 % bovine serum albumin in 1.5 ml Microfuge tubes for 3 h at 4°C with continuous slow rotation.
The tubes were centrifuged (1 min, Eppendorf Microfuge) and the supernatants quickly aspirated. Cell pellets were assayed for radioactivity bound. Background binding to DAUDI cells was 1-5% of the input. The results were analysed by the method of Scatchard (1949; Tinoco et al., 1978 (Fig.  2) . F(ab)2 dissociated slowly under these conditions and a dissociation was measured in only four out of nine experiments. They provide a lower limit for the half-time of dissociation of 50min. With competing non-radioactive antibody the rate of dissociation of Fab only slightly increased, whereas F(ab)2 dissociated much faster with a half-time of 17 min. Increasing the concentration of competing antibody beyond 50,ug/ml did not result in further increase in the rate of dissociation. This indicates that preferential rebinding of the combining sites of 1251-F(ab)2 occurs even when an excess of competing antibody is present. Values for the affinity of Fab and the avidity of F(ab)2 calculated from the experimentally determined on and off rate constants (Fig. 3a, Table 1 ). No binding to other HLA-A,B antigens including A28 and A28* was detected.
Scatchard plots for MA2.1-F(ab)2 were heterogeneous, unlike that found with MA2.1-Fab or any of the PA2.1 species (Fig. 3b) . At either end of the range were experiments that gave linear graphs with different slopes. For HL-60 and A2M1 the slope was low and approximates that of the Fab. MICH gave a steeper slope and JY an intermediate result that at high antibody concentrations approximated Fab binding to MICH and at low antibody concentrations F(ab)2 binding to MICH (Fig. 3b) . This suggested that, at the end point of the experiment, MA2.1-F(ab)2 bound to JY in both univalent and bivalent forms. Lower antibody concentrations, higher cell numbers and cells with higher antigen density all favoured bivalent binding. As shown below, the rate of dissociation of MA2. 1-Fab is low, and true equilibrium was probably not obtained in these assays, although the F(ab)2 bound reached a plateau value. This would occur if the forward rate (Table   3 ). The range was 15-81% bivalent binding. The degree of bivalent binding is roughly correlated with antigen density.
3. Kinetics of association and dissociation of MA2.1. The rate of association of F(ab)2 was slightly higher than for Fab, and in the same range seen with PA2. 1 fragments (Fig. 4, Table 4) .
Dissociation of MA2.1-F(ab)2 or -Fab at 40C in the absence of competing, non-radioactive, homologous IgG was not detected. At room temperature, dissociation of Fab (t-100 min), but not F(ab)2, occurred in the absence of competing IgG (Fig 5) .
When competing antibody at lOO,ug/ml was included, dissociation of F(ab)2 as well as Fab was seen. The rate was -9 times faster at room temperature than at 40C for Fab and -8 times faster for F(ab)2. At each temperature the dissociation rate for Fab was about twice that for F(ab)2.
The dissociation of Fab at 40C in the presence of competing antibody gave a value for k-1 of 4.0x 10-5, corresponding to a dissociation time (tj) of (Karush, 1976 (Karush, , 1978 and for PA2.1 is 68. This is related to the equilibrium constant for the reaction relating antibody bound with one and two combining sites.
In a theoretical treatment of the binding of bivalent antibodies to cell surfaces at equilibrium, Reynolds (1979) concentration within the range 2 x 10-10M-6.6 x 10-9M, corresponding to 2.5 x 105-8 x 106 molecules per cell (Table 1 ). The graphs shown in Fig. 6 are of 1/v against 1/[L12 and are those giving the best fit to a straight line. The best fit was with 2 x 106 HLA-A2 molecules per cell. K2 was calculated from the gradient by using the affinity of Fab (2 x 107m-1) as K1 and a value of V* of 6.8 x 10-15 litre. V* was obtained by assuming the cells were spheres of radius 6,um and that cellmembrane-bound F(ab)2 and HLA moved in a volume equal to the product of the cell-surface area and 15nm (150A). The value of K2 obtained was 1.3 x 104M-1 for the best straight line and in the range 3 x 103m-1-3 x 104m-for the lines plotted in Fig. 6 Calculation of the ratio 3VK1/<r>Na for PA2.1 gives a value of 4.6 x 103M-1 for K2. The cells were again assumed to be spheres of radius 6,um.
The avidities from Scatchard analysis probably underestimate the contribution of bivalent binding. More realistic models give values of K2 for PA2.1 that are 3 x 103-3 x 104M-1 which are significantly larger than 68 M-1. These are all low compared with the theoretical maximum as given by one-quarter of the square of the single-site affinity (Reynolds, 1979) . A contributing factor may be strain induced by complex-formation. The identical binding constant of PA2.1-IgG and F(ab)2 eliminates involvement of the Fc region. Other variables that can decrease K2 are due to the cell surface and are poorly understood. For example it has been assumed that the cells are perfect spheres with a uniform distribution of antigen. If true, then the mean separation of HLA-A2 molecules is about 50nm (500A), a distance much greater than the separation of the Fab arms of an IgG molecule. Lateral diffusion of A2 in the lipid bilayer is therefore required for establishing bivalent complexes, and the diffusion rate will affect the value of K2. For HLA on B-cell lines the time taken for a movement of 50 nm is -0. Is (Smith et al., 1982) . This is slow compared with the motion of antibody from solution to the cell surface and can explain why high-affinity antibodies such as MA2. 1 give significant amounts of univalent binding.
